MURRAY A. GOLDBERG

Corporate Board Profile

Tech Score: 0/100

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filing Date	Source Excerpt
2018-04-25	Murray A. Goldberg Independent Director Committees: Audit Finance and Investment Mr. Goldberg joined the Board of Directors in July 2017. Mr. Goldberg served in various leadership roles at Regeneron Pharmaceuticals from 1995 to 2015, including as Senior Vice President of Administration and Assistant Secretary from 2013 to 2015, as Chief Financial Officer and Senior Vice President, Finance and Administration and Assistant Secretary from 1995 to 2013 and as Treasurer from 1995 to 2012. From 1991 to 1995, Mr. Goldberg served as Chief Financial Officer and Vice President of Finance and Treasurer of PharmaGenics Inc. and as a director of PharmaGenics. From 1987 to 1990, he was a Managing Director at the Chase Manhattan Bank, and from 1973 to 1987, he held various managerial positions in finance and corporate development at American Cyanamid Company. Mr. Goldberg has served as a director of Aerie Pharmaceuticals since 2013 and serves as the chairman of its audit committee. Mr. Goldberg received a Bachelors degree in engineering from New York University, a Masters degree in international economics from the London School of Economics and an M.B.A. from the University of Chicago. 2017 Director Compensation Murray A. Goldberg 85,957 130,001 215,958
2019-04-16	Murray A. Goldberg Independent Director Committees: Audit, Human Resources and Compensation, Finance and Investment, Compliance. 2018 Director Compensation: Murray A. Goldberg Fees Earned or Paid in Cash ($) 115,712, Stock Awards ($) 130,002, Total 245,714.

Filing Date

Source Excerpt

2018-04-25

Murray A. Goldberg Independent Director Committees: Audit Finance and Investment Mr. Goldberg joined the Board of Directors in July 2017. Mr. Goldberg served in various leadership roles at Regeneron Pharmaceuticals from 1995 to 2015, including as Senior Vice President of Administration and Assistant Secretary from 2013 to 2015, as Chief Financial Officer and Senior Vice President, Finance and Administration and Assistant Secretary from 1995 to 2013 and as Treasurer from 1995 to 2012. From 1991 to 1995, Mr. Goldberg served as Chief Financial Officer and Vice President of Finance and Treasurer of PharmaGenics Inc. and as a director of PharmaGenics. From 1987 to 1990, he was a Managing Director at the Chase Manhattan Bank, and from 1973 to 1987, he held various managerial positions in finance and corporate development at American Cyanamid Company. Mr. Goldberg has served as a director of Aerie Pharmaceuticals since 2013 and serves as the chairman of its audit committee. Mr. Goldberg received a Bachelors degree in engineering from New York University, a Masters degree in international economics from the London School of Economics and an M.B.A. from the University of Chicago. 2017 Director Compensation Murray A. Goldberg 85,957 130,001 215,958

2019-04-16

Murray A. Goldberg Independent Director Committees: Audit, Human Resources and Compensation, Finance and Investment, Compliance. 2018 Director Compensation: Murray A. Goldberg Fees Earned or Paid in Cash ($) 115,712, Stock Awards ($) 130,002, Total 245,714.

Data sourced from SEC filings. Last updated: 2026-02-03